Targeting Arachidonic Acid Pathway with Natural Ingredients from Traditional Chinese Medicine for Cancer Prevention and Therapy

被引:0
作者
Liu, Hui [1 ]
Yu, Jiahui [1 ]
Dong, Yajie [2 ]
Rezeng, Caidan [3 ,4 ]
Li, Xiuming [5 ,6 ]
机构
[1] Chengde Med Univ, Sch Tradit Chinese Med, Dept Prescript & TCM, Chengde, Hebei, Peoples R China
[2] Chengde Cty Hosp Tradit Chinese Med, Dept Pediat, Chengde, Peoples R China
[3] Qinghai Univ Nationalities, Sch Pharm, Xining, Peoples R China
[4] Minist Educ, Engn Res Ctr Pharmaceut Chinese Mat Med & New Drug, Beijing 100029, Peoples R China
[5] Chengde Med Univ, Affiliated Hosp, Dept Urol, Chengde 067000, Hebei, Peoples R China
[6] Hebei Key Lab Panvascular Dis, Chengde 067000, Hebei, Peoples R China
基金
中国国家自然科学基金;
关键词
Arachidonic acid; traditional Chinese medicine; cancer therapy; Natural ingredients; NF-KAPPA-B; PROSTATE-CANCER; ELLAGIC ACID; EXPRESSION; INFLAMMATION; CELLS; CYTOCHROME-P450; CYCLOOXYGENASE; RESVERATROL; APIGENIN;
D O I
10.1177/1934578X241290975
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In the process of cancer transformation, arachidonic acid (AA) serves as an important metabolic pathway, contributing to the production of carcinogens by participating in the enzyme metabolic processes, like phospholipase A2, cyclooxygenases, cytochrome P450, and lipoxygenases. Chemopreventive drugs for various cancers have been developed from natural products that inhibit the AA pathway. Moreover, different monomers and components of traditional Chinese medicine (TCM) are widely suggested to be effective on preventing and treating cancer chemically. The present work focused on analyzed different therapeutic methods for natural ingredients from TCM, targeting the metabolic pathways of three enzymes within the AA pathway. Additionally, we summarized the substantial effect of TCM in effectively inhibiting tumors by regulating this pathway.
引用
收藏
页数:12
相关论文
共 125 条
[61]   Cancer - Inflammation by remote control [J].
Mantovani, A .
NATURE, 2005, 435 (7043) :752-753
[62]   Curcumin and lung cancer-a review [J].
Mehta, Hiren J. ;
Patel, Vipul ;
Sadikot, Ruxana T. .
TARGETED ONCOLOGY, 2014, 9 (04) :295-310
[63]   Cyclooxygenases and the cardiovascular system [J].
Mitchell, Jane A. ;
Kirkby, Nicholas S. ;
Ahmetaj-Shala, Blerina ;
Armstrong, Paul C. ;
Crescente, Marilena ;
Ferreira, Plinio ;
Pires, Maria Elisa Lopes ;
Vaja, Ricky ;
Warner, Timothy D. .
PHARMACOLOGY & THERAPEUTICS, 2021, 217
[64]   Humanized neurofibroma model from induced pluripotent stem cells delineates tumor pathogenesis and developmental origins [J].
Mo, Juan ;
Anastasaki, Corina ;
Chen, Zhiguo ;
Shipman, Tracey ;
Papke, Jason ;
Yin, Kevin ;
Gutmann, David H. ;
Le, Lu Q. .
JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (01)
[65]  
Mouchlis Varnavas D., 2016, Advances in Biological Regulation, V61, P17, DOI [10.1016/j.jbior.2015.11.011, 10.1016/j.jbior.2015.11.011]
[66]   PHOSPHOLIPASE A(2) ENZYMES - REGULATION AND PHYSIOLOGICAL-ROLE [J].
MUKHERJEE, AB ;
MIELE, L ;
PATTABIRAMAN, N .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (01) :1-10
[67]   Novel functions of phospholipase A2s: Overview [J].
Murakami, Makoto .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2019, 1864 (06) :763-765
[68]   Recent progress in phospholipase A2 research: From cells to animals to humans [J].
Murakami, Makoto ;
Taketomi, Yoshitaka ;
Miki, Yoshimi ;
Sato, Hiroyasu ;
Hirabayashi, Tetsuya ;
Yamamoto, Kei .
PROGRESS IN LIPID RESEARCH, 2011, 50 (02) :152-192
[69]   LOX-1 and cancer: an indissoluble liaison [J].
Murdocca, M. ;
De Masi, C. ;
Pucci, S. ;
Mango, R. ;
Novelli, G. ;
Di Natale, C. ;
Sangiuolo, F. .
CANCER GENE THERAPY, 2021, 28 (10-11) :1088-1098
[70]   Liposomes Targeting P21 Activated Kinase-1 (PAK-1) and Selective for Secretory Phospholipase A2 (sPLA2) Decrease Cell Viability and Induce Apoptosis in Metastatic Triple-Negative Breast Cancer Cells [J].
Najahi-Missaoui, Wided ;
Quach, Nhat D. ;
Somanath, Payaningal R. ;
Cummings, Brian S. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (24) :1-15